The COVID-19 pandemic may be receding but the diabetes pandemic rages on Hindrik MulderTove Fall Editorial 16 March 2022 Pages: 915 - 916
Maturation of beta cells: lessons from in vivo and in vitro models Tom BarsbyTimo Otonkoski Review Open access 04 March 2022 Pages: 917 - 930
The insulin market reaches 100 David BeranEdwin A. M. GaleJohn S. Yudkin Commentary Open access 11 March 2022 Pages: 931 - 935
Characteristics of adults with type 1 diabetes and treatment-resistant problematic hypoglycaemia: a baseline analysis from the HARPdoc RCT Peter JacobLaura Pottsfor the HARPdoc study group Article Open access 24 March 2022 Pages: 936 - 948
Incidence of newly diagnosed diabetes after Covid-19 Wolfgang RathmannOliver KussKarel Kostev Short Communication Open access 16 March 2022 Pages: 949 - 954
Diabetes, GDF-15 and incident heart failure: the atherosclerosis risk in communities study Justin B. Echouffo-TcheuguiNatalie DayaElizabeth Selvin Article 11 March 2022 Pages: 955 - 963
Mortality trends in type 1 diabetes: a multicountry analysis of six population-based cohorts Paz L. D. RuizLei ChenDianna J. Magliano Article Open access 22 March 2022 Pages: 964 - 972
Young-onset diabetes in Asian Indians is associated with lower measured and genetically determined beta cell function Moneeza K. SiddiquiRanjit Mohan AnjanaViswanathan Mohan Article Open access 05 March 2022 Pages: 973 - 983
XBP1 maintains beta cell identity, represses beta-to-alpha cell transdifferentiation and protects against diabetic beta cell failure during metabolic stress in mice Kailun LeeJeng Yie ChanD. Ross Laybutt Article Open access 22 March 2022 Pages: 984 - 996
Opposing effects on regulated insulin secretion of acute vs chronic stimulation of AMP-activated protein kinase Marie-Sophie Nguyen-TuJoseph HarrisGuy A. Rutter Article Open access 16 March 2022 Pages: 997 - 1011
Mucosal-associated invariant T cells are associated with insulin resistance in childhood obesity, and disrupt insulin signalling via IL-17 Ronan BerginDavid KinlenAndrew E. Hogan Short Communication Open access 19 March 2022 Pages: 1012 - 1017
Opposing roles of the entero-pancreatic hormone urocortin-3 in glucose metabolism in rats Kaare V. GrunddalSamuel A. J. TrammellRune E. Kuhre Article Open access 24 March 2022 Pages: 1018 - 1031
Loss of function of renal Glut2 reverses hyperglycaemia and normalises body weight in mouse models of diabetes and obesity Leticia Maria de Souza CordeiroLauren BainbridgeKavaljit H. Chhabra Article 15 March 2022 Pages: 1032 - 1047
High-intensity interval training for 12 weeks improves cardiovascular autonomic function but not somatosensory nerve function and structure in overweight men with type 2 diabetes Gidon J. BönhofAlexander StromDan Ziegler Article Open access 11 March 2022 Pages: 1048 - 1057
Long-term outcomes of dietary carbohydrate restriction for HbA1c reduction in type 2 diabetes mellitus are needed Junren KangEnling Ma Letter 31 March 2022 Pages: 1058 - 1059
Long-term outcomes of dietary carbohydrate restriction for HbA1c reduction in type 2 diabetes mellitus are needed. Reply to Kang J and Ma E [letter] Mads N. ThomsenArne AstrupThure Krarup Letter 01 April 2022 Pages: 1060 - 1062
Correction to: The suitability of patient-reported outcome measures used to assess the impact of hypoglycaemia on quality of life in people with diabetes: a systematic review using COSMIN methods Jill CarltonJoanna LeavissJane Speight Correction 23 March 2022 Pages: 1063 - 1063
Correction to: Defining the underlying defect in insulin action in type 2 diabetes Thiago M. BatistaNida HaiderC. Ronald Kahn Correction 23 March 2022 Pages: 1064 - 1064
